Zydus Lifesciences Limited

Zydus Lifesciences extends closing date for Sterling Biotech API acquisition to September 30, 2026. Sterling Biotech still completing conditions precedent under the Business Transfer Agreement. Regula

Zydus Lifesciences forms 50:50 joint venture Zydus Sunshine with Sunshine Healthcare to manufacture pharmaceuticals in Sri Lanka. Zydus will invest up to USD 5 million for a 50% stake in the JV, which

Zydus Lifesciences discloses insider share transactions under SEBI regulations related to its recent buyback offer. Promoter Zydus Family Trust accepted 63.5 lakh shares, reducing its holding from 74.

Zydus Lifesciences discloses transmission of 10,000 shares from deceased promoter Jasodaben Patel to Samar Patel. The off-market transaction was executed on May 22, 2026 and intimated to the company o